Publications by authors named "Garry Morefield"

Claim this Profile
F
Formulation Attributes Impact Immune Profile of an Oral and Thermostable COVID-19 Subunit Vaccine.
Elodie Burlet, Nissy Thomas, Shanna Carwell, Brett W Gershman, Garry L Morefield

Vaccines (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Group A Streptococcus Vaccine Targeting the Erythrogenic Toxins SpeA and SpeB Is Safe and Immunogenic in Rabbits and Does Not Induce Antibodies Associated with Autoimmunity.
Matthew J Troese, Elodie Burlet, Madeleine W Cunningham, Kathy Alvarez, Rebecca Bentley, Garry L Morefield

Vaccines (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical safety study of a recombinant Streptococcus pyogenes vaccine formulated with aluminum adjuvant.
Harm HogenEsch, Anisa Dunham, Elodie Burlet, Fangjia Lu, Yung-Yi C Mosley, Garry Morefield

J Appl Toxicol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a recombinant fusion protein vaccine formulation to protect against Streptococcus pyogenes.
Garry Morefield, Graham Touhey, Fangjia Lu, Anisa Dunham, Harm HogenEsch

Vaccine· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rational, systematic approach for the development of vaccine formulations.
Garry L Morefield

AAPS J· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock.
Garry L Morefield, Ralph F Tammariello, Bret K Purcell, Patricia L Worsham, Jennifer Chapman

J Immune Based Ther Vaccines· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome.
Garry L Morefield, Lynn D Hawkins, Sally T Ishizaka, Teri L Kissner, Robert G Ulrich

Clin Vaccine Immunol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of adsorption mechanism of antigens by aluminum-containing adjuvants to in vitro elution in interstitial fluid.
Dongping Jiang, Garry L Morefield, Harm HogenEsch, Stanley L Hem

Vaccine· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid.
Garry L Morefield, Dongping Jiang, Ilia Z Romero-Mendez, Robert L Geahlen, Harm Hogenesch

Vaccine· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
Garry L Morefield, Anna Sokolovska, Dongping Jiang, Harm HogenEsch, J Paul Robinson

Vaccine· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of adsorbed antigen in mono-valent and combination vaccines.
Garry L Morefield, Harm HogenEsch, J Paul Robinson, Stanley L Hem

Vaccine· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of thermal treatment during the preparation of aluminum hydroxide adjuvant on the protein adsorption capacity during aging.
Euphemie A Dandashli, Qinjian Zhao, Silaja Yitta, Garry L Morefield, Joe L White

Pharm Dev Technol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis